GEMAROMA
Gem Aromatics Limited
Specialty and commodity chemicals manufacturer
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
gemaromatics.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-19
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Gem Aromatics makes aroma and flavour ingredients such as mint products, clove derivatives (including eugenol), cooling agents and safranal, selling mainly to fragrance, flavour, oral care, confectionery and consumer goods companies in India and export markets.
Company snapshot
47thBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
- ✓Cash flow from operations is higher than reported profit — earnings quality looks solid.
- ✗Net margin is very thin at 0.4% — little room for error if costs rise.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Sales | 88 Cr | 90 Cr | 79 Cr | 110 Cr | 99 Cr |
| Operating expenses (approx.) | 73 Cr | 86 Cr | 72 Cr | 95 Cr | 96 Cr |
| EBITDA | 15 Cr | 3 Cr | 7 Cr | 16 Cr | 3 Cr |
| OPM % | 17.0% | 3.4% | 8.9% | 14.2% | 3.3% |
| Other income | 1 Cr | 0.98 Cr | -2 Cr | 0.30 Cr | 0.16 Cr |
| Interest | 4 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr |
| Depreciation | 2 Cr | 3 Cr | 9 Cr | 9 Cr | 9 Cr |
| Profit before tax | 11 Cr | -3 Cr | -6 Cr | 4 Cr | -9 Cr |
| Tax % | 26.0% | -2.4% | 15.8% | 74.9% | 7.8% |
| Net profit | 8 Cr | -3 Cr | -5 Cr | 1 Cr | -8 Cr |
| EPS (₹) | ₹1.70 | ₹-0.04 | ₹-1.04 | ₹0.19 | ₹-1.56 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 366 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 326 Cr | Sign in free for the trailing twelve months |
| EBITDA | 41 Cr | Sign in free for the trailing twelve months |
| OPM % | 11.1% | Sign in free for the trailing twelve months |
| Other income | 0.90 Cr | Sign in free for the trailing twelve months |
| Interest | 13 Cr | Sign in free for the trailing twelve months |
| Depreciation | 23 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 6 Cr | Sign in free for the trailing twelve months |
| Tax % | 77.6% | Sign in free for the trailing twelve months |
| Net profit | 1 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹0.28 | Sign in free for the trailing twelve months |
| Dividend payout % | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 10 Cr |
| Reserves | 439 Cr |
| Borrowings | 150 Cr |
| Other liabilities | 42 Cr |
| Total liabilities | 642 Cr |
| Fixed assets (net) | 243 Cr |
| CWIP | 6 Cr |
| Investments | 0 Cr |
| Loans & advances | 0.15 Cr |
| Inventories | 234 Cr |
| Trade receivables | 77 Cr |
| Cash & bank | 8 Cr |
| Other assets | 74 Cr |
| Total assets | 642 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 30 Cr |
| Cash from investing | -101 Cr |
| Cash from financing | 78 Cr |
| Net cash flow | 5 Cr |
| Free cash flow (OCF − Capex) | -66 Cr |
Ratios
| Metric | Mar 2026 |
|---|---|
| ROCE % | 3.2% |
| ROE % | 0.3% |
| Debtor days | 76 |
| Inventory days | 263 |
| Days payable | 22 |
| Cash conversion cycle | 317 |
| OCF / EBITDA % | 72.6% |
| Debt / equity | 0.33 |
| Current ratio | 2.16 |
| Net debt / EBITDA | 3.48 |